The European Union's pharmaceutical sector is in a perpetual state of progression. With rigorous regulations, growing patient needs, and the swift pace of development, navigating this intricate landscape requires a tactical approach. Pharmaceutical companies must adapt to these challenges by implementing cutting-edge technologies, working with key